🔗 Permalink

Inventor profile of:

Michael MARK

City:

Biberach

Country:

Germany

Published Applications:

Last publication date:

2013-04-18

Top Assignees for applications by Michael MARK

The entities that hold a legal rights for patent applications filed by inventor MARK Michael:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH 14 Ingelheim am Rhein, Germany
Boehringer Ingelheim Pharma GmbH Co. KG 9 Ingelheim, Germany
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 6 Ingelheim, Germany
BOEHRINGER INGELHEIM PHARMA GMBH &CO. KG 3 Ingelheim am Rhein, Germany
Boehringer Ingelheim Pharma KG 2 Ingelheim, Germany
BOEHRINGER INGELHEIM PHARMA & CO. KG 2 Ingelheim am Rhein, Germany
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 1 Ingelheim am Rheim, Germany
BOEHRINGER INGELHEIM PHARMA GMBH AND CO. KG 1 Ingelheim am Rhein, Germany

Recent patent applications by MARK Michael

Michael MARK from Biberach, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2013-04-18

US20130096076A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR

#2 | 2011-11-10

US20110275561A1

Human necessities

Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

#3 | 2011-10-27

US20110263617A1

Human necessities

Combination therapy for the treatment of diabetes and related conditions

#4 | 2011-08-11

US20110195917A1

Human necessities

Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate

#5 | 2011-08-04

US20110190322A1

Human necessities

PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES

#6 | 2011-08-04

US20110190277A1

Human necessities

PHARMACEUTICAL COMBINATION FOR THE PREVENTION OR TREATMENT OF CARDIOVASCULAR, CARDIOPULMONARY, PULMONARY OR RENAL DISEASES

#7 | 2011-06-16

US20110144095A1

Chemistry; metallurgy

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#8 | 2011-06-16

US20110144083A1

Chemistry; metallurgy

Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions

#9 | 2011-05-12

US20110112069A1

Human necessities

PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES

#10 | 2011-04-28

US20110098240A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR

#11 | 2011-04-21

US20110092510A1

Human necessities

DPP-IV INHIBITORS FOR USE IN THE TREATMENT OF NAFLD

#12 | 2011-03-17

US20110065731A1

Human necessities

Uses of DPP-IV inhibitors

#13 | 2011-02-24

US20110046087A1

Human necessities

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#14 | 2011-02-24

US20110046076A1

Human necessities

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#15 | 2010-08-12

US20100204250A1

Chemistry; metallurgy

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#16 | 2010-07-08

US20100173916A1

Chemistry; metallurgy

Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions

#17 | 2010-06-10

US20100144703A1

Chemistry; metallurgy

XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS

#18 | 2009-10-15

US20090258856A1

Chemistry; metallurgy

Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions

#19 | 2009-08-04

US10634047

Purine derivatives, the preparation thereof and their use as pharmaceutical compositions

#20 | 2009-07-14

US10716141

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#21 | 2009-05-21

US20090131432A1

Chemistry; metallurgy

Xanthine derivates, their preparation and their use in pharmaceutical compositions

#22 | 2009-04-09

US20090093457A1

Chemistry; metallurgy

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#23 | 2009-02-24

US10636088

Xanthine derivatives, their preparation and their use in pharmaceutical compositions

#24 | 2009-01-27

US10695597

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#25 | 2008-10-16

US20080255159A1

Chemistry; metallurgy

8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions

#26 | 2008-10-09

US20080249089A1

Chemistry; metallurgy

8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions

#27 | 2008-08-05

US10639036

8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions

#28 | 2007-12-06

US20070281940A1

Human necessities

Uses of DPP-IV inhibitors

#29 | 2006-11-02

US20060247226A1

Chemistry; metallurgy

XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS

#30 | 2006-09-14

US20060205711A1

Chemistry; metallurgy

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#31 | 2005-03-31

US20050070594A1

Human necessities

Use of angiotensin II receptor antagonists

#32 | 2005-02-03

US20050026921A1

Chemistry; metallurgy

Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions

#33 | 2005-01-27

US20050020574A1

Chemistry; metallurgy

Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions

#34 | 2005-01-06

US20050004193A1

Human necessities

Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary, or renal diseases

InventorID:

198754 ⎘